Get the Stockscreener App
11.00
1.50%
0.163
Daxor Corporation stock is traded at $11.00, with a volume of 3,712.
It is up +1.50% in the last 24 hours and up +19.78% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$10.84
Open:
$11
24h Volume:
3,712
Relative Volume:
0.14
Market Cap:
$53.21M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
36.63
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+3.77%
1M Performance:
+19.78%
6M Performance:
+51.87%
1Y Performance:
+31.26%
1-Day Range:
$10.66
$11.00
1-Week Range:
$10.36
$11.02
52-Week Range:
$6.55
$11.38
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
11.00 | 54.68M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Using economic indicators to assess Daxor Corporation potentialMarket Performance Recap & Stock Timing and Entry Methods - Newser
Bollinger Bands Expand on Daxor Corporation — Volatility Ahead2025 Sector Review & Stock Portfolio Risk Management - thegnnews.com
FDA Clears Daxor Corporation’s Rapid Blood Volume Analysis System - Medical Product Outsourcing
Daxor Corporation stock prediction for this weekEarnings Overview Summary & Weekly Breakout Stock Alerts - Newser
Is now a turning point for Daxor Corporation2025 Market Overview & Real-Time Volume Analysis - Newser
How to interpret RSI for Daxor Corporation stockDividend Hike & Long-Term Growth Plans - Newser
Will a bounce in Daxor Corporation offer an exitEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-08-19 22:48:12 - Newser
Will earnings trigger a reversal in Daxor CorporationQuarterly Profit Report & Fast Entry and Exit Trade Plans - Newser
Published on: 2025-08-19 16:39:40 - Newser
Applying big data sentiment scoring on Daxor CorporationJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Relative strength of Daxor Corporation in sector analysis2025 Market Overview & Daily Risk Controlled Trade Plans - Newser
Will Daxor Corporation stock recover after recent drop - Newser
Using flow based indicators on Daxor CorporationDip Buying & Fast Momentum Stock Entry Tips - Newser
Published on: 2025-08-19 07:38:31 - Newser
What indicators show strength in Daxor CorporationJuly 2025 Chart Watch & Verified Momentum Watchlists - Newser
Is This the Dip to Buy in Daxor CorporationJuly 2025 Analyst Calls & Weekly Consistent Profit Watchlists - newsimpact.co.kr
Chart based analysis of Daxor Corporation trendsQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - Newser
Daxor Corporation Inches Above Key Support — Safe to HoldJuly 2025 Opening Moves & Verified Technical Signals - sundaytimes.kr
Daxor Corporation Chart Enters High Volatility ZoneJuly 2025 Price Swings & AI Enhanced Market Trend Forecasts - metal.it
What’s the recovery path for long term holders of Daxor CorporationDay Trade & Daily Profit Maximizing Tips - Newser
Tick level data insight on Daxor Corporation volatility2025 Retail Activity & High Return Stock Watch Alerts - Newser
Key resistance and support levels for Daxor CorporationWeekly Investment Report & Growth Focused Stock Reports - Newser
Is Daxor Corporation a candidate for recovery play2025 Market Overview & Comprehensive Market Scan Insights - Newser
Daxor Corporation Earnings Report Breakdown: What Investors Should KnowPortfolio Gains Summary & Risk Managed Investment Entry Signals - Newser
What makes Daxor Corporation stock price move sharplyJuly 2025 Action & Expert Curated Trade Setups - Newser
Top chart patterns to watch in Daxor CorporationMarket Growth Summary & Real-Time Chart Breakout Alerts - Newser
Daxor Corporation Shows Support at Fibonacci Level2025 Valuation Update & Smart Money Movement Tracker - newsyoung.net
Quant Strategy Flags Daxor Corporation for EntryAnalyst Downgrade & Stock Timing and Entry Methods - newsimpact.co.kr
How Daxor Corporation stock performs during market volatilityRecession Risk & Accurate Buy Signal Notifications - Newser
How high can Daxor Corporation stock price go in 2025Take Profit & Verified Entry Point Signals - Newser
FDA clearances: Imris, Daxor Corp., Tandem Diabetes Care - Modern Healthcare
Is Daxor Corporation forming a bottoming baseJuly 2025 Closing Moves & Weekly Setup with ROI Potential - Newser
Applying chart zones and confluence areas to Daxor Corporation2025 Support & Resistance & Short-Term High Return Ideas - Newser
Will Daxor Corporation continue its uptrendFree AI Driven Stock Trend Forecast - Newser
Can machine learning forecast Shimmick Corporation recoverySafe Momentum Strategy With Trend Analysis - Newser
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available - GlobeNewswire
Daxor BVA Gets FDA Clearance, Celebrates Nasdaq Listing Milestone - AInvest
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):